the impact of mrd status by clonoseq® in patients with mcl, dlbcl & fl treated with car-t therapy
Published 1 year ago • 75 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
4:20
differential dynamics of response between axi-cel and tisa-cel in r/r b-cell lymphoma
-
1:46
phase ii study of acalabrutinib plus rice in r/r dlbcl
-
1:38
using pet to predict failure to salvage therapy in patients with dlbcl
-
3:01
how the treatment of dlbcl and fl are changing in the uk
-
10:56
liso-cel for second-line r/r aggressive large b-cell nhl
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
3:21
radiotherapy bridging for axi-cel in large b-cell lymphoma
-
1:26
the impact of covid-19 on car-t therapy
-
1:28
novel ultra-sensitive mrd profiling tool predicts outcomes in dlbcl after frontline treatment
-
3:41
240620 diary - apple store trx exchange kl